Release test results
99.555%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 50.35 mg
Related impurities (total)0.445%
Endotoxin<1.0 EU/mg
HPLC retention time5.8 min
MethodHPLC + LC-MS
ResultPass · meets spec
Lot record
CompoundSS-31 (Elamipretide)
Presentation50 MG
Lot numberRGX-26-SS-1033
COA numberNS-2026-05034
Test date02 Sep 2026
Release date05 Sep 2026
Independent labNordicstar Labs
StatusCurrent
SS-31 (Elamipretide) — lot history
| Lot | Presentation | Tested | HPLC purity | Status |
|---|---|---|---|---|
| RGX-26-SS-768 | 10 MG | Sep 8, 2026 | 99.746% | Superseded |
| RGX-26-SS-667 | 50 MG | Sep 8, 2026 | 99.666% | Superseded |
| RGX-26-SS-668 | 10 MG | Sep 5, 2026 | 99.742% | Superseded |
| RGX-26-SS-767 | 50 MG | Sep 3, 2026 | 99.704% | Superseded |
| RGX-26-SS-1032 | 10 MG | Sep 2, 2026 | 99.731% | Current |
| RGX-26-SS-1033 this lot | 50 MG | Sep 2, 2026 | 99.555% | Current |
!
Research use only
This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →